To CADe or not to CADe - evidence for the benefit of CAD for increased yield of colonoscopy.
1/5 보강
Computer -Aided Detection (CADe) has emerged as a promising tool for enhancing colonoscopy during colorectal cancer screening.
APA
Rerknimitr R (2026). To CADe or not to CADe - evidence for the benefit of CAD for increased yield of colonoscopy.. Best practice & research. Clinical gastroenterology, 80, 102091. https://doi.org/10.1016/j.bpg.2026.102091
MLA
Rerknimitr R. "To CADe or not to CADe - evidence for the benefit of CAD for increased yield of colonoscopy.." Best practice & research. Clinical gastroenterology, vol. 80, 2026, pp. 102091.
PMID
41724543 ↗
Abstract 한글 요약
Computer -Aided Detection (CADe) has emerged as a promising tool for enhancing colonoscopy during colorectal cancer screening. This manuscript critically examines the evidence supporting CADe's role in improving the yield of colonoscopy, focusing on its impact on lesion detection, miss rates, and real-time decision-making, especially for less experienced endoscopists. We review relevant clinical trials, studies, and meta-analyses to provide a comprehensive assessment of CADe's impact on detection rates, diagnostic accuracy, cost-effectiveness, colonoscopy training, reimbursement and patient outcomes. Despite challenges such as the need for adequate bowel preparation, a degree of false-positive rate, and potential lower sensitivity in detecting sessile serrated lesions (SSL), CADe holds significant promise for improving colonoscopy outcomes by enabling constant detection of colorectal neoplasia and contributing to lower adenoma miss rate. This review also covers the factors influencing the decision to use or not use CADe in various clinical contexts. Further development of AI-powered tools can potentially extend the benefits of CADe by enabling polyp characterization and automated quality control during colonoscopy, addressing factors such as withdrawal time and bowel preparation adequacy.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.